As part of the out-licensing deal with Tabuk, Biocon will develop and manufacture the products, and Tabuk will commercialise them
Going forward, the fastest-growing regions in the generic pharmaceuticals market will be South America and the Middle East, where growth will be at CAGRs of 10.1% and 9.4% respectively
Applications supported by positive results from the pivotal Phase 3 POETYK-PSO clinical trial program demonstrating superior efficacy of deucravacitinib over Otezla (apremilast)
Obseva announced previously that the company has entered into a partnership with Syneos Health to support commercialization of linzagolix in the US and EU
It is the first blood test able to detect early-stage Breast Cancer with high accuracy in women above the age of 40 years
The submission is based on Phase 2/3 study of mRNA-1273 in children ages 6 to 11
Generalized pustular psoriasis is characterized by episodes of widespread eruptions of painful, sterile pustules
Filing marks first protein-based vaccine submitted to MHRA for authorization
If authorized, molnupiravir could be the first oral antiviral medicine for the treatment of Covid-19
It is the first orally administered therapy for the treatment of two types of ANCA-associated vasculitis approved in Japan
Subscribe To Our Newsletter & Stay Updated
